Health Catalyst, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $311.1M | $306.6M | $295.9M | $276.2M | $241.9M |
| Research and development | $49.8M | $58.0M | $72.6M | $75.7M | $62.7M |
| Operating expenses | $312.5M | $210.6M | $258.7M | $273.2M | $261.2M |
| Operating income | -$160.9M | -$69.8M | -$126.9M | -$140.0M | -$143.7M |
| Pretax income | -$177.3M | -$69.2M | -$117.8M | — | — |
| Income tax expense | $716,000 | $333,000 | $356,000 | -$4.3M | -$6.9M |
| Net income | -$178.0M | -$69.5M | -$118.1M | -$137.4M | -$153.2M |
| Balance Sheet | |||||
| Cash and equivalents | $50.8M | $249.6M | $106.3M | $116.3M | $193.2M |
| Current assets | $169.3M | $465.6M | $393.4M | $427.8M | $508.4M |
| Total assets | $502.6M | $858.9M | $701.8M | $752.3M | $832.1M |
| Current liabilities | $89.6M | $325.9M | $89.0M | $82.5M | $93.1M |
| Total liabilities | $256.9M | $493.7M | $334.9M | $327.3M | $310.0M |
| Total debt | $160.8M | $392.4M | $230.0M | — | — |
| Stockholders' equity | $245.8M | $365.2M | $366.9M | $425.0M | $522.1M |
| Cash Flow Statement | |||||
| Cash from operations | $731,000 | $14.6M | -$33.1M | -$35.3M | -$23.1M |
| Depreciation and amortization | $15.0M | $12.8M | $12.6M | $11.1M | $5.5M |
| Stock-based compensation | $27.0M | $40.1M | $55.8M | $72.1M | $65.1M |
| Capital expenditure | $968,000 | $1.6M | $1.2M | $2.2M | $10.4M |
| Free cash flow | -$237,000 | $12.9M | -$34.3M | -$37.4M | -$33.6M |
| Share repurchases | $5.0M | $0 | $1.8M | $8.4M | $0 |
| Impairments | $105.4M | $0 | $0 | $0 | $0 |
Shares outstanding 73.9M · Free float 52.0%
Annual filing data through FY ended December 31, 2025; float as of July 14, 2026.